Hyperlipidemia
Hyperlipidemia
Embedded Files
Protocols
Protocols
Guidelines
Guidelines
Dyslipidemia
Dyslipidemia
2022 ACC Expert Consensus Decision Pathway on the Role of Nonstatin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk
2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol
2020 AACE/ACE Update: Algorithm on the Management of Dyslipidemia
2017 AACE/ACE Guidelines for Management of Dyslipidemia and Prevention of Cardiovascular Disease
2020 VA/DoD Clinical Practice Guideline for Management of Dyslipidemia for Cardiovascular Disease Risk Reduction
2019 EESC/EAS Guidelines for the Management of Dyslipidaemias: Lipid Modification to Reduce Cardiovascular Risk
Hypertriglyceridemia
Hypertriglyceridemia
2021 ACC Expert Consensus Decision Pathway on the Management of ASCVD Risk Reduction in Patients With Persistent Hypertriglyceridemia
Presentations & Research Posters
Presentations & Research Posters
BempedoicAcidPrimaryPreventionJournalClub.pdfBempedoic Acid for Primary Prevention of Cardiovascular Events in Statin-Intolerant Patients
Bempedoic Acid for Primary Prevention of Cardiovascular Events in Statin-Intolerant Patients
Date: August 7th, 2023
Speaker(s):
Rebecca Schein, PharmD Candidate, Class of 2024
5.12.21 S Levine - Low Dose ASA for Primary Prevention and Cancer.pdfLow Dose Aspirin: Primary Prevention and Cancer Risk
Low Dose Aspirin: Primary Prevention and Cancer Risk
Date: May 27th, 2021
Speaker(s):
Sophy Levine, PharmD
PGY1 Pharmacy Resident - Cambridge Health Alliance
Summary Charts & Documents
Summary Charts & Documents
Page updated
Report abuse